Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Hausman

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The New England Journal of Medicine|May 27, 2005
Sargramostim for active Crohn's diseaseJoshua R Korzenik, Brian K Dieckgraefe, John F Valentine, et al.
Molecular Ecology|June 20, 2006
Chloroplast DNA phylogeography of European ashes, Fraxinus sp. (Oleaceae): roles of hybridization and life history traitsM Heuertz, S Carnevale, S Fineschi, et al.
Annals of the New York Academy of Sciences|January 16, 2010
Interferon lambda as a potential new therapeutic for hepatitis CDennis M Miller, Kevin M Klucher, Jeremy A Freeman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2008
Phase I study of recombinant interleukin-21 in patients with metastatic melanoma and renal cell carcinomaJohn A Thompson, Brendan D Curti, Bruce G Redman, et al.
Tree Physiology|December 17, 2005
Metabolic responses to water deficit in two Eucalyptus globulus clones with contrasting drought sensitivityA L Shvaleva, F Costa E Silva, E Breia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2012
A multicenter phase I trial of PX-866, an oral irreversible phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumorsDavid S Hong, Daniel W Bowles, Gerald S Falchook, et al.
Neuro-Oncology|January 22, 2015
Phase II study of PX-866 in recurrent glioblastomaMarshall W Pitz, Elizabeth A Eisenhauer, Mary V MacNeil, et al.
Molecular Oncology|April 24, 2013
A patient tumor transplant model of squamous cell cancer identifies PI3K inhibitors as candidate therapeutics in defined molecular binsStephen B Keysar, David P Astling, Ryan T Anderson, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The New England Journal of Medicine|May 27, 2005
Sargramostim for active Crohn's diseaseJoshua R Korzenik, Brian K Dieckgraefe, John F Valentine, et al.
Molecular Ecology|June 20, 2006
Chloroplast DNA phylogeography of European ashes, Fraxinus sp. (Oleaceae): roles of hybridization and life history traitsM Heuertz, S Carnevale, S Fineschi, et al.
Annals of the New York Academy of Sciences|January 16, 2010
Interferon lambda as a potential new therapeutic for hepatitis CDennis M Miller, Kevin M Klucher, Jeremy A Freeman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2008
Phase I study of recombinant interleukin-21 in patients with metastatic melanoma and renal cell carcinomaJohn A Thompson, Brendan D Curti, Bruce G Redman, et al.
Tree Physiology|December 17, 2005
Metabolic responses to water deficit in two Eucalyptus globulus clones with contrasting drought sensitivityA L Shvaleva, F Costa E Silva, E Breia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2012
A multicenter phase I trial of PX-866, an oral irreversible phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumorsDavid S Hong, Daniel W Bowles, Gerald S Falchook, et al.
Neuro-Oncology|January 22, 2015
Phase II study of PX-866 in recurrent glioblastomaMarshall W Pitz, Elizabeth A Eisenhauer, Mary V MacNeil, et al.
Molecular Oncology|April 24, 2013
A patient tumor transplant model of squamous cell cancer identifies PI3K inhibitors as candidate therapeutics in defined molecular binsStephen B Keysar, David P Astling, Ryan T Anderson, et al.
Pageof 2